Exploring kidney dialysis costs in the United States: a scoping review

References

• Centers for Disease Control and Prevention [internet]. Chronic kidney disease in the United States, 2023. Accessed June 2023. Available from: https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-facts.html.
   Google Scholar
• United States Renal Data System [internet]. 2022 USRDS annual data report. 2022. Accessed June 2023. Available from: https://usrds-adr.niddk.nih.gov/2022.
   Google Scholar
• Nordyke RJ, Reichert H, Bylsma LC, et al. Costs attributable to arteriovenous fistula and arteriovenous graft placements in hemodialysis patients with medicare coverage. Am J Nephrol. 2019;50(4):320–328. doi: 10.1159/000502507.
   PubMed Web of Science ®Google Scholar
• West J, Chan HK, Molony DA, et al. Insurance status and emergency department visits associated with hemodialysis in Texas. JAMA Netw Open. 2020;3(2):e1921447. doi: 10.1001/jamanetworkopen.2019.21447.
   PubMed Web of Science ®Google Scholar
• West J, Chan HK, Wang H, et al. Emergency department visits for hemodialysis by insurance status in the United States. J Am Coll Emerg Physicians Open. 2022;3(2):e12698. doi: 10.1002/emp2.12698.
   PubMedGoogle Scholar
• Cervantes L, Rizzolo K, Tummalapalli SL, et al. Economic impact of a change in medicaid coverage policy for dialysis care of undocumented immigrants. J Am Soc Nephrol. 2023;34(7):1132–1134. doi: 10.1681/ASN.0000000000000139.
   PubMed Web of Science ®Google Scholar
• Shafqat F, Das S, Wheatley MA, et al. The impact of "emergency-only" hemodialysis on hospital cost and resource utilization. West J Emerg Med. 2023;24(2):206–209. doi: 10.5811/westjem.2022.11.58360.
   PubMed Web of Science ®Google Scholar
• Nguyen OK, Vazquez MA, Charles L, et al. Association of scheduled vs emergency-only dialysis with health outcomes and costs in undocumented immigrants with end-stage renal disease. JAMA Intern Med. 2019;179(2):175–183. doi: 10.1001/jamainternmed.2018.5866.
   PubMed Web of Science ®Google Scholar
• Ng BP, Laxy M, Shrestha SS, et al. Prevalence and medical expenditures of diabetes-related complications among adult medicaid enrollees with diabetes in eight U.S. states. J Diabetes Complications. 2021;35(3):107814. doi: 10.1016/j.jdiacomp.2020.107814.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang P, Shao H, et al. Medical costs associated with diabetes complications in medicare beneficiaries aged 65 years or older with type 1 diabetes. Diabetes Care. 2022;46(1):149–155. doi: 10.2337/dc21-2151.
   Web of Science ®Google Scholar
• Deshpande R, Stepanova M, Golabi P, et al. Prevalence, mortality and healthcare utilization among medicare beneficiaries with hepatitis C in haemodialysis units. J Viral Hepat. 2019;26(11):1293–1300. doi: 10.1111/jvh.13173.
   PubMed Web of Science ®Google Scholar
• Khanna V, Sakthivelnathan V, Senthil T, et al. Dialysis patients undergoing total hip arthroplasty have higher rates of morbidity and mortality and incur greater healthcare costs: a national database study from 367,894 patients. Indian J Orthop. 2023;57(2):336–343. doi: 10.1007/s43465-022-00799-x.
   PubMed Web of Science ®Google Scholar
• Danese MD, Fox KM, Duryea JL, et al. The rate, cost and outcomes of parathyroidectomy in the United States dialysis population from 2016-2018. BMC Nephrol. 2022;23(1):220. doi: 10.1186/s12882-022-02848-x.
   PubMed Web of Science ®Google Scholar
• League RJ, Eliason P, McDevitt RC, et al. Variability in prices paid for hemodialysis by employer-sponsored insurance in the US from 2012 to 2019. JAMA Netw Open. 2022;5(2):e220562. doi: 10.1001/jamanetworkopen.2022.0562.
   PubMed Web of Science ®Google Scholar
• League RJ, Eliason P, McDevitt RC, et al. Assessment of spending for patients initiating dialysis care. JAMA Netw Open. 2022;5(10):e2239131. doi: 10.1001/jamanetworkopen.2022.39131.
   PubMed Web of Science ®Google Scholar
• Trish E, Fiedler M, Ning N, et al. Payment for dialysis services in the individual market. JAMA Intern Med. 2021;181(5):698–699. doi: 10.1001/jamainternmed.2020.7372.
   PubMed Web of Science ®Google Scholar
• Kaplan JM, Niu J, Ho V, et al. A comparison of US medicare expenditures for hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 2022;33(11):2059–2070. doi: 10.1681/ASN.2022020221.
   PubMed Web of Science ®Google Scholar
• Weinhandl ED, Saffer TL, Aragon M. Hidden costs associated with conversion from peritoneal dialysis to hemodialysis. Kidney360. 2022;3(5):883–890. doi: 10.34067/KID.0007692021.
   PubMedGoogle Scholar
• Lin E, Lung KI, Chertow GM, et al. Challenging assumptions of outcomes and costs comparing peritoneal and hemodialysis. Value Health. 2021;24(11):1592–1602. doi: 10.1016/j.jval.2021.05.017.
   PubMed Web of Science ®Google Scholar
• Yeung E, Bello AK, Levin A, et al. Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey. BMJ Open. 2021;11(7):e047245. doi: 10.1136/bmjopen-2020-047245.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services [internet]. End-stage renal disease (ESRD). 2023. Accessed June 2023. Available from: https://www.medicare.gov/basics/end-stage-renal-disease.
   Google Scholar
• Wetmore JB, Tzivelekis S, Collins AJ, et al. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care. BMC Nephrol. 2016;17(1):53. doi: 10.1186/s12882-016-0267-x.
   PubMedGoogle Scholar
• Davis J, Robinson S, Murunga A, et al. PUK3 incident costs of dialysis initiation among medicare beneficiaries with advanced chronic kidney disease. Value Health. 2021;24(1):S234. doi: 10.1016/j.jval.2021.04.1171.
   Google Scholar
• Lin E, Ly B, Duffy E, et al. Medicare advantage plans pay large markups to consolidated dialysis organizations. Health Aff (Millwood). 2022;41(8):1107–1116. doi: 10.1377/hlthaff.2021.02009.
   PubMed Web of Science ®Google Scholar
• Nichols GA, Ustyugova A, Déruaz-Luyet A, et al. Health care costs by type of expenditure across eGFR stages among patients with and without diabetes, cardiovascular disease, and heart failure. J Am Soc Nephrol. 2020;31(7):1594–1601. doi: 10.1681/ASN.2019121308.
   PubMed Web of Science ®Google Scholar
• Mu F, Betts KA, Woolley JM, et al. Prevalence and economic burden of hyperkalemia in the United States medicare population. Curr Med Res Opin. 2020;36(8):1333–1341. doi: 10.1080/03007995.2020.1775072.
   PubMed Web of Science ®Google Scholar
• Sibbel S, Sato R, Hunt A, et al. The clinical and economic burden of pneumonia in patients enrolled in medicare receiving dialysis: a retrospective, observational cohort study. BMC Nephrol. 2016;17(1):199. doi: 10.1186/s12882-016-0412-6.
   PubMedGoogle Scholar
• Betts KA, Woolley JM, Mu F, et al. The cost of hyperkalemia in the United States. Kidney Int Rep. 2018;3(2):385–393. doi: 10.1016/j.ekir.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Sy J, Streja E, Grimes B, et al. The marginal cost of frailty among medicare patients on hemodialysis. Kidney Int Rep. 2020;5(3):289–295. doi: 10.1016/j.ekir.2019.11.020.
   PubMed Web of Science ®Google Scholar
• Thamer M, Lee TC, Wasse H, et al. Medicare costs associated with arteriovenous fistulas among US hemodialysis patients. Am J Kidney Dis. 2018;72(1):10–18. doi: 10.1053/j.ajkd.2018.01.034.
   PubMed Web of Science ®Google Scholar
• Lindquester WS, Dhangana R, Warhadpande S. Bundled medicare payments: trends in utilization and physician payments for dialysis arteriovenous fistula and graft maintenance procedures from 2010 to 2018. AJR Am J Roentgenol. 2020;215(4):785–789. doi: 10.2214/AJR.19.22675.
   PubMed Web of Science ®Google Scholar
• Trivedi PS, Jensen AM, Brown MA, et al. Cost analysis of dialysis access maintenance interventions across physician specialties in U.S. Medicare beneficiaries. Radiology. 2020;297(2):474–481. doi: 10.1148/radiol.2020192403.
   PubMed Web of Science ®Google Scholar
• Wagner JK, Fish L, Weisbord SD, et al. Hemodialysis access cost comparisons among incident tunneled catheter patients. J Vasc Access. 2020;21(3):308–313. doi: 10.1177/1129729819874307.
   PubMed Web of Science ®Google Scholar
• Al-Balas A, Lee T, Young CJ, et al. The clinical and economic effect of vascular access selection in patients initiating hemodialysis with a catheter. J Am Soc Nephrol. 2017;28(12):3679–3687. doi: 10.1681/ASN.2016060707.
   PubMed Web of Science ®Google Scholar
• Al-Balas A, Shariff S, Lee T, et al. Clinical outcomes and economic impact of starting hemodialysis with a catheter after predialysis arteriovenous fistula creation. Am J Nephrol. 2019;50(3):221–227. doi: 10.1159/000502050.
   PubMed Web of Science ®Google Scholar
• Liao M, Li Y, Kianifard F, et al. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis. BMC Nephrol. 2016;17(1):25. doi: 10.1186/s12882-016-0238-2.
   PubMedGoogle Scholar
• United States Renal Data System [internet]. 2019 USRDS annual data report. 2019. Available from: https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds/prior-data-reports/2019.
   Google Scholar
• United States Renal Data System [internet]. 2021 USRDS annual data report: epidemiology of kidney disease in the United States. 2021. Accessed December 2022. Available from: https://usrds-adr.niddk.nih.gov/2021.
   Google Scholar
• Hornberger J, Hirth RA. Financial implications of choice of dialysis type of the revised medicare payment system: an economic analysis. Am J Kidney Dis. 2012;60(2):280–287. doi: 10.1053/j.ajkd.2012.03.010.
   PubMed Web of Science ®Google Scholar
• Flanagin EP, Chivate Y, Weiner DE. Home dialysis in the United States: a roadmap for increasing peritoneal dialysis utilization. Am J Kidney Dis. 2020;75(3):413–416. doi: 10.1053/j.ajkd.2019.10.013.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services [internet]. Advancing American kidney health. Accessed September 2022. Available from: https://aspe.hhs.gov/sites/default/files/private/pdf/262046/AdvancingAmericanKidneyHealth.pdf.
   Google Scholar
• Baerman EA, Kaplan J, Shen JI, et al. Cost barriers to more widespread use of peritoneal dialysis in the United States. J Am Soc Nephrol. 2022;33(6):1063–1072. doi: 10.1681/asn.2021060854.
   PubMed Web of Science ®Google Scholar
• Liu FX, Ghaffari A, Dhatt H, et al. Economic evaluation of urgent-start peritoneal dialysis versus urgent-start hemodialysis in the United States. Medicine (Baltimore). 2014;93(28):e293. doi: 10.1097/MD.0000000000000293.
   PubMed Web of Science ®Google Scholar
• Neil N, Guest S, Wong L, et al. The financial implications for medicare of greater use of peritoneal dialysis. Clin Ther. 2009;31(4):880–888. doi: 10.1016/j.clinthera.2009.04.004.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare & Medicaid Services. Federal Register. Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule: CMS-42 CFR Parts 410, 413 and 414. 2010. Accessed March 2024. Available from: http://www.gpo.gov/fdsys/pkg/FR-2010-08-12/pdf/2010-18466.pdf.
   Google Scholar